Compare
Astrana Health vs Tenet Health (ASTH vs THC)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Astrana Health (ASTH) returned +3.8% and Tenet Health (THC) +35.8%; so far this year the figures are +39.1% and +42.6%.
Tenet Health is the larger company by market value, about 11.7 times the size of Astrana Health.
On trailing earnings, ASTH trades at 31.9 times and THC at 8.2 times.
Revenue grew +35.1% at ASTH and +6.2% at THC over the last year.
Data as of the latest close. Not investment advice.
Relative performance
| ASTH | THC | |
|---|---|---|
| Price | $34.50 | $283.33 |
| 1-day | -11.56% | -1.09% |
| YTD | +39.06% | +42.58% |
| 1 year | +3.79% | +35.81% |
| 3 years | +13.82% | +433.68% |
| Market cap | $1.9B | $22.6B |
| P/E | 31.9 | 8.2 |
| P/S | 0.49 | 1.02 |
| P/B | 2.25 | 4.14 |
| Revenue growth | +35.10% | +6.20% |
| EPS growth | +440.00% | +134.50% |
| Gross margin % | 11.0 | — |
| Net margin % | 1.4 | 13.1 |
| ROE % | 6.2 | 53.3 |
| Debt / equity | 1.08 | 2.43 |
| FCF yield % | 5.2 | 14.8 |
| Dividend yield % | — | — |
| Beta | 0.59 | 0.55 |
| RSI (14) | 39.8 | 60.2 |
| Technical rating |